Wells Fargo says litigation costs could exceed provisions by $1.7 billion
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
A Wells Fargo Bank is shown in Charlotte, North Carolina, U.S., September 26, 2016. REUTERS/Mike Blake
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
(Reuters) - Wells Fargo & Co, under fire for its sales tactics, said on Thursday its litigation costs could rise as much as $1.7 billion more than the amount it had already earmarked in provisions.
The San Francisco bank had said in August that litigation costs could exceed provisions by as much as $1 billion.
Wells Fargo also said on Thursday that the U.S. Securities and Exchange Commission (SEC) is investigating the bank's sales practices. (http://bit.ly/2eXIj3s)
The bank has faced intense regulatory scrutiny since September over the opening of as many as 2 million unauthorized accounts, a scandal that led to the departure of former chief executive John Stumpf last month.
Wells Fargo in September agreed to pay regulators $185 million in a settlement over the case.
The Wall Street Journal had reported on Wednesday that the SEC is probing whether Wells Fargo violated rules around investor disclosures and other matters relating to the sales tactics scandal.
The company said it could not determine if a resolution of its sales practices could have a "material adverse effect" on its financial condition.
Goldman Sachs Group Inc separately said on Thursday that it had scaled back its estimate of the legal costs it may face beyond what it has set aside, to $1.7 billion from $2 billion. (http://bit.ly/2fy8sHX)
(Reporting by Sruthi Shankar in Bengaluru; Editing by Sai Sachin Ravikumar)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herbalife (HLF) Provides Q4, FY17 Guidance in Memorandum for $1.325B Credit Facility; Lowers FY17 Sales Guidance
- Asta Funding, Inc. (ASFI) Commences 5.3M Share Tender Offer for Its Common Stock
- Interpace Diagnostics (IDXG) Enters $4M Common Stock Securities Purchase Agreement
Create E-mail Alert Related CategoriesReuters
Related EntitiesGoldman Sachs, Wells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!